Atsena Therapeutics Receives FDA Designation for Treatment of Severe Congenital Eye Disease Using Gene Therapy
Atsena Therapeutics has been granted Regenerative Medicine Advanced Therapy designation from the FDA to continue their research on a cure to Leber congenital amaurosis. Patients with this disease are missing a gene that regulates retinal function and visually-guided behavior, causing blindness at an early age.
UF, UF Health Announce New Research and Technology Incubator
The University of Florida and the Norman Fixel Institute for Neurological Diseases at UF Health announced today the creation of a new Research and Technology Innovation Incubator.
Selected for support through UF President Ben Sasse’s strategic funding process, this 20,000-square-foot space will serve as a state-of-the-art hub for interdisciplinary collaborations among the colleges. The $960,000 initiative also will establish the Fixel Institute as an international destination for leading-edge science and collaboration.
New Pest Management Hub Will Address Florida’s Buggiest Problems
The University of Florida Institute of Food and Agricultural Sciences (UF/IFAS) will create a new network focused on finding novel ways to manage bugs and pests in homes and businesses, known as the Innovation Hub for Urban Pest Management.
University of Florida Shows Advances in AI Farming
The UF Southwest Research and Education Center in Immokalee, part of the Institute of Food and Agricultural Sciences, is merging the powers of farming and AI. Researchers at the center are utilizing the latest technologies like drones and advanced AI systems to revolutionize the way we grow our food.
President’s Office Announces $5.4 Million for Strategic Funding Awardees
The President's Office at the University of Florida announced $5.4 million in awards for Strategic Funding. Various colleges and departments across campus received awards to fund their research projects and initiatives. The funding initiative is designed to advance the student experience and interdisciplinary scholarship.
Tech Tuesday: NysnoBio
On this Tech Tuesday segment, Melanie Morón interviews Jennifer Johnston from NysnoBio to discuss the company's work in gene therapy to treat Parkinson's disease.
Cannabix Completes Initial Electronics Testing on Contactless Alcohol Breathalyzer, Commences International Certification Plans
Cannabix Technologies Inc., developer of breath testing devices for law enforcement and the workplace reports that it has completed preliminary third-party testing on its Contactless Alcohol Breathalyzer (“CAB”) wall mounted device.
The CAB device is part of the Company’s portfolio of marijuana and alcohol screening devices. The Company will be selecting a new product name for the CAB and create new product branding in the coming weeks.
Cannabix Technologies began as a UF startup, utilizing technology created by Chemistry Professor Richard Yost.
Medicine’s New Frontier: Clinicians and Researchers Aim To Combine Expertise With Artificial Intelligence To Improve Patients’ Lives
As UF continues to make strides in the field of AI, researchers are putting a focus on improving patient care. At the College of Medicine, these new technologies will improve patient's lives while building the foundation for new training methods to teach the next generation of physicians.
UF Working To Expand Your Options for Decorative Holiday Plants
University of Florida scientists want to add caladiums, known for their beautiful foliage, as an option for seasonal occasions. Bob Hartman, who runs Classic Caladiums LLC, a nursery in Avon Park, is enlisting the help of UF/IFAS plant breeder Zhanao Deng to research caladium bulb storage.
UF Opens Malachowsky Hall for Data Science & Information Technology
The University of Florida Friday held a celebratory ribbon cutting for the Malachowsky Hall for Data Science & Information Technology. The new building is named after UF alumnus and NVIDIA co-founder Chris Malachowsky, and funded by a combination of state funds as well as private and college funds.
